GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genetic Signatures GSS.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.07

-4.23%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Genetic Signatures — daily ASX:GSS

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Genetic Signatures on TradingView ↗
Market value
A$15.4m
Last close × shares
Volume
14.9k
Shares, 9 Nov 2026

About Genetic Signatures

Its shares trade on ASX under the ticker GSS.AX. It has been listed since 31 March 2015. In the fiscal year to 30 June 2026, it reported revenue of A$14.5m and a net loss of A$14.0m. At that date it held total assets of A$38.5m and shareholders' equity of A$35.7m.

Genetic Signatures Ltd. is a molecular diagnostics company, which focuses on the development of real-time PCR based products for the routine detection of infectious diseases. The Company’s principal activities include research and commercialization of identifying individual genetic signatures to identify diseases and the sale of associated products into the diagnostic and research marketplaces. The firm is focused on the development and commercialization of its platform technology, 3base. Its MDx 3base platform technology provides high-volume hospitals and pathology laboratories with the ability to screen for an array of infectious pathogens, with a high degree of specificity, in a rapid throughput (time-to-result) environment. The company designs and manufactures a suite of real-time Polymerase Chain Reaction (PCR) based products for the routine detection of infectious diseases under the EasyScreen brand. Its products include EasyScreen Pan-Enteric Detection Kit, EasyScreen STI Genital Pathogen Detection, EasyScreen Viral Meningitis Detection Kit and others.

Figures and description from our data supplier, not checked against the company's own report.

More about Genetic Signatures →

Latest on Genetic Signatures

Our reporting

We have not reported on Genetic Signatures yet.

Next results

16 Feb 2027

Due on 16 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Genetic Signatures's ticker?

Genetic Signatures trades as GSS.AX on ASX, under ISIN AU000000GSS4.

What was Genetic Signatures's last closing price?

0.07 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Genetic Signatures next report results?

Results are expected on 16 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.